Thursday, April 14, 2016
Cudd Hall lobby
Open to the Tulane community
Reception to follow
Dr. Steven Paul is an expert in neuroscience with an extensive record in central nervous system (CNS) drug discovery and development. As president and CEO of Voyager Therapeutics, a clinical-stage gene therapy company, he helps develop life-changing gene therapies for severe CNS diseases. Dr. Paul's previous roles include serving as president of Eli Lilly Research Laboratories, as the Scientific Director of the National Institute of Mental Health, and as a professor of neuroscience, psychiatry, and pharmacology at Weill Cornell Medical College. Dr. Paul holds a B.A. in biology and psychology from Tulane University and an M.S. and M.D. from the Tulane University School of Medicine.
This event is part of the John J. Witmeyer III Dean's Colloquium series, which invites distinguished alumni back to campus to discuss their careers and professions. Sponsored by the Newcomb-Tulane College Office of Cocurricular Programs. For more information, call 504-865-5728 or email email@example.com.
Previous Dean’s Colloquia
2016-17 Dean's Colloquium: Roger Ervin
2014-15 Dean’s Colloquium: Meria Carstarphen
2013-14 Dean's Colloquium: Alex McMurray
2012-13 Dean's Colloquium: Attorney Ira Sorkin
2011-12 Dean's Colloquium: NASA Astronaut Doug Hurley
2010-11 Dean's Colloquium: Actor Bryan Batt
2009-10 Dean's Colloquium: EPA Administrator Lisa Jackson
2008-09 Dean's Colloquium: NPR Correspondent Gwen Thompkins
2007-08 Dean’s Colloquium: Appraiser and “History Detectives” star Elyse Luray